First human test for new 'Double-Target' antibody begins
NCT ID NCT07439263
Summary
This is a first-in-human study to check the safety and side effects of a new antibody drug called HB2198 in healthy people. About 32 healthy adults will receive a single dose of the drug or a placebo. The main goal is to see how well the drug is tolerated and how it moves through the body over about two months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.